SBC / revenue moved 70 bp lower
SBC / revenue changed -70 basis points from the comparable as-filed period.
4.69%→3.99%3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed -70 basis points from the comparable as-filed period.
Stock-based compensation changed +7.7% from the comparable as-filed period.
Research & development changed -2.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.